Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Racemization. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105237532A reveals enzymatic route for L-praziquantel. Offers high optical purity and greener manufacturing for reliable pharmaceutical intermediate supply chains.
Patent CN102442994A details a novel atmospheric racemization method for S-Lipoic Acid, enabling cost-effective production of high-purity R-Lipoic Acid intermediates.
Patent CN108777958B details a novel racemization method for 4-aminoindan derivatives, enabling cost reduction in agrochemical manufacturing by recycling inactive enantiomers.
Novel scalable route for L-penicillamine HCl via efficient racemization and resolution. Delivers high-purity pharmaceutical intermediates with optimized cost structures.
Advanced racemization technology for ortho-substituted 1-phenylethylamine derivatives enables efficient recycling of unwanted enantiomers in agrochemical manufacturing.
Patent CN102285961B details a cost-effective racemization method for duloxetine intermediates, enhancing yield and reducing environmental impact for pharmaceutical manufacturing.
Patent CN102586384B reveals a novel deracemization method for D-amino acids using Alcaligenes faecalis, offering high optical purity and simplified downstream processing for pharmaceutical supply chains.
Patent CN103342676A reveals high-purity D-tryptophan synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN101052604A details a catalytic de-enrichment method for chiral substrates, offering cost-effective recycling of unwanted isomers for pharmaceutical intermediate manufacturing.
Patent CN104450853B reveals green recycling method. Reduces waste and ensures high-purity pharmaceutical intermediates for cost-effective manufacturing and supply chain reliability.
Patent CN102757356B details a cost-effective splitting process for D-HPG. Enhances supply chain reliability and reduces waste in API intermediate manufacturing significantly.
Patent CN107502647A reveals high-purity L-glufosinate-ammonium production via enzymatic deracemization, offering significant cost reduction and supply chain reliability for agrochemical manufacturers.
Novel resolution method for levodopa intermediate ensures high purity and cost efficiency. Reliable supply chain partner for pharmaceutical manufacturing needs.
Patent CN102317248A details an efficient route for (S)-3-cyclohexene-1-carboxylic acid, a key FXa inhibitor intermediate, offering significant cost and supply chain advantages.
Novel base-catalyzed racemization process for lipid disorder intermediates. Reduces waste and enhances supply chain efficiency for global pharmaceutical manufacturers.
Patent CN105755095A enables high-yield enzymatic deracemization. Delivers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN113355367B reveals high-efficiency LlKAR enzyme for deracemization. Offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN108911972B details a novel racemization recovery method for sitafloxacin intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Advanced one-step resolution technology for high-purity Lacosamide intermediates. Discover cost-effective manufacturing and reliable supply chain solutions for chiral pharmaceutical compounds.
Novel base-catalyzed racemization of larotrectinib intermediate enables recycling of S-isomer, reducing costs and waste for API manufacturing.